NDC 66576-322

PHENAGIL

Chlorpheniramine Maleate,phenylephrine Hcl

PHENAGIL is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Syntho Pharmaceuticals, Inc.. The primary component is Chlorpheniramine Maleate; Phenylephrine Hydrochloride.

Product ID66576-322_e15024e7-870f-e0bf-e053-2a95a90a545f
NDC66576-322
Product TypeHuman Otc Drug
Proprietary NamePHENAGIL
Generic NameChlorpheniramine Maleate,phenylephrine Hcl
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2022-06-15
Marketing CategoryOTC MONOGRAPH FINAL /
Application Numberpart341
Labeler NameSyntho Pharmaceuticals, Inc.
Substance NameCHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE
Active Ingredient Strength4 mg/1; mg/1
Pharm ClassesAdrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 66576-322-01

100 TABLET in 1 BOTTLE (66576-322-01)
Marketing Start Date2022-06-15
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "PHENAGIL" or generic name "Chlorpheniramine Maleate,phenylephrine Hcl"

NDCBrand NameGeneric Name
58552-322PHENAGILPHENYLEPHRINE HCL AND CHLORPHENIRAMINE MALEATE
58552-337PHENAGILChlorpheniramine maleate, Dextromethorphan HBr and Phenylephrine HCL
66576-322PHENAGILChlorpheniramine Maleate,Phenylephrine HCl
66576-337PHENAGILChlorpheniramine maleate, Dextromethorphan HBr and Phenylephrine HCL

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.